Anti-IL12B重组抗体|科研级 Briakinumab ( 布雷奴单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-IL12B重组抗体|科研级 Briakinumab ( 布雷奴单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-IL12B重组抗体|科研级 Briakinumab ( 布雷奴单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1099

Alias

科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab

Molecular Name

Briakinumab

Size

1mg, 5mg

CAS Number

339308-60-0

Isotype

IgG1 Lambda

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

146.5 kDa

Applications

FC, IP, ELISA, Neut, FuncS

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6376H9874N1722O1992S44

Target

IL12B[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ